State Street’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.35M | Buy |
459,611
+10,450
| +2% | +$167K | ﹤0.01% | 2768 |
|
|
2025
Q1 | $6.83M | Sell |
449,161
-351,032
| -44% | -$5.34M | ﹤0.01% | 2744 |
|
|
2024
Q4 | $16.2M | Buy |
800,193
+388,213
| +94% | +$7.87M | ﹤0.01% | 2332 |
|
|
2024
Q3 | $10.6M | Buy |
411,980
+83,949
| +26% | +$2.16M | ﹤0.01% | 2564 |
|
|
2024
Q2 | $4.22M | Buy |
328,031
+294,288
| +872% | +$3.78M | ﹤0.01% | 2999 |
|
|
2024
Q1 | $773K | Buy |
+33,743
| New | +$773K | ﹤0.01% | 3534 |
|
|
2023
Q4 | – | Sell |
-6,545
| Closed | -$184K | – | 4489 |
|
|
2023
Q3 | $184K | Hold |
6,545
| – | – | ﹤0.01% | 3965 |
|
|
2023
Q2 | $199K | Sell |
6,545
-28,928
| -82% | -$879K | ﹤0.01% | 4013 |
|
|
2023
Q1 | $667K | Buy |
35,473
+1,809
| +5% | +$34K | ﹤0.01% | 3652 |
|
|
2022
Q4 | $343K | Buy |
33,664
+551
| +2% | +$5.62K | ﹤0.01% | 3901 |
|
|
2022
Q3 | $871K | Buy |
33,113
+233
| +0.7% | +$6.13K | ﹤0.01% | 3623 |
|
|
2022
Q2 | $1.48M | Buy |
32,880
+6,733
| +26% | +$304K | ﹤0.01% | 3551 |
|
|
2022
Q1 | $2.57M | Buy |
26,147
+7,547
| +41% | +$743K | ﹤0.01% | 3473 |
|
|
2021
Q4 | $2.84M | Buy |
18,600
+5,692
| +44% | +$870K | ﹤0.01% | 3515 |
|
|
2021
Q3 | $1.75M | Buy |
12,908
+3,412
| +36% | +$463K | ﹤0.01% | 3643 |
|
|
2021
Q2 | $1.4M | Buy |
+9,496
| New | +$1.4M | ﹤0.01% | 3607 |
|